202 related articles for article (PubMed ID: 26348421)
1. Update on ventilator-associated pneumonia.
Guillamet CV; Kollef MH
Curr Opin Crit Care; 2015 Oct; 21(5):430-8. PubMed ID: 26348421
[TBL] [Abstract][Full Text] [Related]
2. Ventilator associated pneumonia in the ICU: where has it gone?
Guillamet CV; Kollef MH
Curr Opin Pulm Med; 2015 May; 21(3):226-31. PubMed ID: 25730768
[TBL] [Abstract][Full Text] [Related]
3. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
Werarak P; Kiratisin P; Thamlikitkul V
J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
[TBL] [Abstract][Full Text] [Related]
4. Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management.
Barbier F; Andremont A; Wolff M; Bouadma L
Curr Opin Pulm Med; 2013 May; 19(3):216-28. PubMed ID: 23524477
[TBL] [Abstract][Full Text] [Related]
5. Do guidelines change outcomes in ventilator-associated pneumonia?
Bassi GL; Ferrer M; Saucedo LM; Torres A
Curr Opin Infect Dis; 2010 Apr; 23(2):171-7. PubMed ID: 20134322
[TBL] [Abstract][Full Text] [Related]
6. Locally derived versus guideline-based approach to treatment of hospital-acquired pneumonia in the trauma intensive care unit.
Becher RD; Hoth JJ; Rebo JJ; Kendall JL; Miller PR
Surg Infect (Larchmt); 2012 Dec; 13(6):352-9. PubMed ID: 23268613
[TBL] [Abstract][Full Text] [Related]
7. Prior antimicrobial therapy duration influences causative pathogens identification in ventilator-associated pneumonia.
Llitjos JF; Amara M; Benzarti A; Lacave G; Bedos JP; Pangon B
J Crit Care; 2018 Feb; 43():375-377. PubMed ID: 29113712
[TBL] [Abstract][Full Text] [Related]
8. De-escalation therapy in ventilator-associated pneumonia.
Niederman MS
Curr Opin Crit Care; 2006 Oct; 12(5):452-7. PubMed ID: 16943725
[TBL] [Abstract][Full Text] [Related]
9. Challenges and opportunities in the treatment of ventilator-associated pneumonia.
Schreiber MP; Shorr AF
Expert Rev Anti Infect Ther; 2017 Jan; 15(1):23-32. PubMed ID: 27771978
[TBL] [Abstract][Full Text] [Related]
10. Management and prevention of ventilator-associated pneumonia caused by multidrug-resistant pathogens.
Grgurich PE; Hudcova J; Lei Y; Sarwar A; Craven DE
Expert Rev Respir Med; 2012 Nov; 6(5):533-55. PubMed ID: 23134248
[TBL] [Abstract][Full Text] [Related]
11. Aerosolized colistin as adjunctive treatment of ventilator-associated pneumonia due to multidrug-resistant Gram-negative bacteria: a prospective study.
Michalopoulos A; Fotakis D; Virtzili S; Vletsas C; Raftopoulou S; Mastora Z; Falagas ME
Respir Med; 2008 Mar; 102(3):407-12. PubMed ID: 18060758
[TBL] [Abstract][Full Text] [Related]
12. High-dose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii.
Betrosian AP; Frantzeskaki F; Xanthaki A; Georgiadis G
Scand J Infect Dis; 2007; 39(1):38-43. PubMed ID: 17366011
[TBL] [Abstract][Full Text] [Related]
13. Utility of ampicillin-sulbactam for empiric treatment of ventilator-associated pneumonia in a trauma population.
McMillian WD; Bednarik JL; Aloi JJ; Ahern JW; Crookes BA
J Trauma; 2010 Oct; 69(4):861-5. PubMed ID: 20938272
[TBL] [Abstract][Full Text] [Related]
14. Use of aerosolized aminoglycosides in the treatment of Gram-negative ventilator-associated pneumonia.
Mohr AM; Sifri ZC; Horng HS; Sadek R; Savetamal A; Hauser CJ; Livingston DH
Surg Infect (Larchmt); 2007 Jun; 8(3):349-57. PubMed ID: 17635058
[TBL] [Abstract][Full Text] [Related]
15. Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy.
Bassetti M; Taramasso L; Giacobbe DR; Pelosi P
Expert Rev Anti Infect Ther; 2012 May; 10(5):585-96. PubMed ID: 22702322
[TBL] [Abstract][Full Text] [Related]
16. Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand.
Inchai J; Liwsrisakun C; Theerakittikul T; Chaiwarith R; Khositsakulchai W; Pothirat C
J Infect Chemother; 2015 Aug; 21(8):570-4. PubMed ID: 26026660
[TBL] [Abstract][Full Text] [Related]
17. Emergence of Antimicrobial Resistance among Pseudomonas aeruginosa: Implications for Therapy.
Lynch JP; Zhanel GG; Clark NM
Semin Respir Crit Care Med; 2017 Jun; 38(3):326-345. PubMed ID: 28578556
[TBL] [Abstract][Full Text] [Related]
18. Microbial cause of ICU-acquired pneumonia: hospital-acquired pneumonia versus ventilator-associated pneumonia.
Luyt CE; Hékimian G; Koulenti D; Chastre J
Curr Opin Crit Care; 2018 Oct; 24(5):332-338. PubMed ID: 30036192
[TBL] [Abstract][Full Text] [Related]
19. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
[TBL] [Abstract][Full Text] [Related]
20. New guidelines for hospital-acquired pneumonia/ventilator-associated pneumonia: USA vs. Europe.
Martin-Loeches I; Rodriguez AH; Torres A
Curr Opin Crit Care; 2018 Oct; 24(5):347-352. PubMed ID: 30063491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
